OPHARMIC TECHNOLOGY

ABOUT OPHARMIC

Opharmic Technology (former Sonikure Technology) is a privately held medical technology company developing novel ocular drug delivery technology and devices. The company was founded in 2016 based on a patented ultrasound-mediated ocular drug delivery technology from the Hong Kong University of Science and Technology. With safety and feasibility well-demonstrated in pre-clinical studies, the technology non-invasively delivers large molecules to the posterior eye segment through the sclera. With the vision to replace invasive intravitreal injections, Opharmic is currently in preparation of two large-scale pre-clinical studies to streamline product development, and to validate additional technology applications.
​
​Awards & Recognitions
  • Deloitte Raising Star Award - 2017
  • 45th International Exhibition of Invention Geneva - Prize of the State of Geneva; Prize of ULBS Romania​ - 2017
  • IET Innovation Award - 2016 Winner (Healthcare)
  • Google We Solve for X - Moonshot Project
  • Kairos' Society K50 - 2015 Global Top 50 Startups
  • Rice Business Plan Competition - 2015 Top 6 Semi-finalist 
  • TiE International Business Plan Competition - 2015 Winner (Hong Kong & Asia); Asia Rising Star Award
  • The HKUST 4th Annual One Million Dollar Entrepreneurship Competition - 2nd Prize Winner​

 Publications & Presentations 
Vertical Divider
In the press
Vertical Divider

Support

About Opharmic
Terms of Use
Contact Us
© COPYRIGHT 2020. ALL RIGHTS RESERVED.